BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36313757)

  • 1. Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy.
    Ran B; Wei F; Gong J; Xu H
    Front Endocrinol (Lausanne); 2022; 13():1004962. PubMed ID: 36313757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
    Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
    J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
    Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
    Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
    Vendrami C; Marques-Vidal P; Gonzalez Rodriguez E; Hans D; Waeber G; Lamy O
    Osteoporos Int; 2022 Jan; 33(1):195-204. PubMed ID: 34409507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
    De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
    Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma.
    Moon JH; Kim KM; Oh TJ; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
    J Clin Endocrinol Metab; 2017 Jan; 102(1):78-85. PubMed ID: 27754806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.
    Chung CW; Choi HS; Kong SH; Park YJ; Park DJ; Ahn HY; Cho SW
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34063726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm.
    Jia H; Qu W; Cai X; Li M; Qian Y; Jiang Z; Zhang Z
    Front Endocrinol (Lausanne); 2023; 14():1286947. PubMed ID: 38075039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
    Shevroja E; Lamy O; Kohlmeier L; Koromani F; Rivadeneira F; Hans D
    J Clin Densitom; 2017; 20(3):334-345. PubMed ID: 28734710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH
    Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
    Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
    Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
    Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Bone Mineral Density and Trabecular Bone Score in Patients with and without Vertebral Fractures and Differentiated Thyroid Cancer with Long-Term Serum Thyrotrophin-Suppressed Therapy.
    Hawkins Carranza F; Arroba CM; López Alvarez MB; Librizzi S; Martínez Díaz Guerra G
    Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer.
    Zou Y; Li B; Wang X; Mao J; Zhang Y
    Medicine (Baltimore); 2022 Dec; 101(48):e31991. PubMed ID: 36482589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Predictive Value of FRAX Adjusted by Trabecular Bone Score for Osteoporotic Fractures in Korean Women: A Community-Based Cohort Study.
    Kim H; Kim JH; Kim MJ; Hong AR; Choi H; Ku E; Lee JH; Shin CS; Cho NH
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):359-366. PubMed ID: 32615720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
    Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
    Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.
    Florez H; Hernández-Rodríguez J; Muxi A; Carrasco JL; Prieto-González S; Cid MC; Espinosa G; Gómez-Puerta JA; Monegal A; Guañabens N; Peris P
    Rheumatology (Oxford); 2020 Jul; 59(7):1574-1580. PubMed ID: 31628810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.
    Hans D; Goertzen AL; Krieg MA; Leslie WD
    J Bone Miner Res; 2011 Nov; 26(11):2762-9. PubMed ID: 21887701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.
    Leslie WD; Aubry-Rozier B; Lix LM; Morin SN; Majumdar SR; Hans D
    Bone; 2014 Oct; 67():10-4. PubMed ID: 24998455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.